FDA inspection
Pfizer Clinical Research Unit, Hopital Erasme: FDA inspection ending May 30, 2024
FDA inspection 1241100 · Voluntary Action Indicated (VAI) · Anderlecht
Key facts
| Inspection ID | 1241100 |
|---|---|
| Firm | Pfizer Clinical Research Unit, Hopital Erasme |
| FEI number | 3007000232 |
| Address | Lennikse Baan 808 |
| City | Anderlecht |
| Country | Belgium |
| Fiscal year | 2024 |
| Inspection end date | May 30, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data